Related Experiment Video
Updated: Jun 17, 2026

09:45
Detection of Copy Number Alterations Using Single Cell Sequencing
Published on: February 17, 2017
CMDS: a population-based method for identifying recurrent DNA copy number aberrations in cancer from high-resolution
Qunyuan Zhang1, Li Ding, David E Larson
1Division of Statistical Genomics, Washington University School of Medicine, St Louis, MO, USA. qunyuan@wustl.edu
Bioinformatics (Oxford, England)
|December 25, 2009
Summary
We developed a new population-based method to detect recurrent copy number aberrations (RCNA) in cancer genomes. This approach is computationally efficient and statistically powerful, outperforming traditional two-step methods for large-scale genomic studies.
Area of Science:
- Genomics
- Cancer Research
- Bioinformatics
Background:
- DNA copy number aberrations (CNA) are key genomic alterations in tumors.
- Recurrent CNAs (RCNA) are particularly significant in tumorigenesis.
- Existing methods for RCNA detection are computationally intensive and may reduce statistical power.
Purpose of the Study:
- To develop a novel, population-based approach for efficient and powerful RCNA detection.
- To overcome the limitations of traditional single-sample CNA calling followed by cross-sample analysis.
- To provide a tool suitable for high-resolution and large-population cancer genome studies.
Main Methods:
- Introduced Correlation Matrix Diagonal Segmentation (CMDS), a population-based method for RCNA detection.
- CMDS analyzes between-chromosomal-site correlations directly from raw intensity ratio data.
- Employs a diagonal transformation strategy to reduce computational burden and increase speed.
Main Results:
- CMDS demonstrated higher statistical power compared to two-step methods in simulations.
- The method successfully identified known CNAs in lung and brain cancer datasets.
- Identified RCNAs associated with oncogenes like EGFR and KRAS.
Conclusions:
- CMDS is a fast, powerful, and easily implemented tool for RCNA analysis.
- The population-based approach is highly suitable for large-scale cancer genome datasets.
- CMDS offers significant advantages for identifying critical genomic alterations in cancer.
